期刊文献+

不同剂量培哚普利治疗对心肌梗死后心力衰竭患者心肌能量消耗水平的影响 被引量:3

下载PDF
导出
摘要 目的分析不同剂量培哚普利治疗对心肌梗死后心力衰竭患者心肌能量消耗水平的影响。方法回顾性分析本院收治的心肌梗死后心力衰竭患者92例分为两组,各46例,对照组行常规剂量培哚普利用药,观察组行高剂量培哚普利用药。结果观察组治疗后LVFS、LVEF、c ESS、MEE、NT-pro BNP、Cr指标均优于对照组(P<0.05)。结论采用培哚普利治疗心肌梗死后心力衰竭,能降低患者的心肌能量消耗,而高剂量的培哚普利治疗效果更佳。
作者 张妍
出处 《中国医药指南》 2015年第28期171-171,共1页 Guide of China Medicine
  • 相关文献

参考文献4

二级参考文献15

  • 1宋浩明,张佳,邓兵,罗明.血管紧张素转换酶抑制剂对慢性心力衰竭患者脑钠肽和去甲肾上腺素的作用[J].中华医学杂志,2005,85(25):1737-1740. 被引量:4
  • 2Kempf T, Peter T, Allhoff T, et al. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol, 2007,50 : 1054-1060.
  • 3Wollert KC, Kempf T, Peter T, et al. Prognostic value of growth differentiation factor-aS in patients with non-ST-ele- vation acute coronary syndrome. Circulation, 2007,115 : 962-971.
  • 4Kempf T, Bjorklund E, Olofsson S, et al. Growth-differentia tion factor 15 improves risk stratification in ST-segment ele- vation myocardial infarction. Eur Heart J, 2007, 28: 2858-2865.
  • 5Lind L, Wallentin L, Kempf T, et al. Growth-differentiation facto-15 is an independent marker of cardiovascular dysfunc- tion and disease in the elderly: Results from the prospective investigation of the vasculature in Uppsala seniors (PIVUS) study. Eur Heart J,2009,20:2346 2353.
  • 6Kempf T, Hom-Wichmann R, Brabant G, et al. Circulatipg concentrations of growth differentiation factor 15 in apparent ly healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich as- say. Clin Chem, 2007,53 : 284-291.
  • 7Van Kimmenade RR, Januzzi JL. Emerging biomarkers in heart failure. Clin Chem, 2012,58: 127-138.
  • 8Kempf T, Eden M, Strelau J, et al. The transformipg growth factor-beta superfamily member growth-differentiation factor- 15 protects the heart from ischemia/reperfusion injury. Circ Res,2006,98:351-360.
  • 9Ago T, Sadoshima J. GDF-15, a cardioprotective TGF-β su- perfamily protein. Circ Res, 2006,98 : 294-297.
  • 10Norozi K, Buchhorn R, Yasin A, et al. Growth differentiation factor 15:An additional diagnostic tool for the risk stratifica- tion of developing heart failure in patients with operated con- genital heart defects. Am Heart J, 2011,162:131-135.

共引文献32

同被引文献21

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部